bioRxivCancer BiologyPreprint
Expression of endoplasmic reticulum mannosyl-oligosaccharide α1, 2-mannosidase regulates tumorigenicity of prostate cancer cells
Abstract
It has been previously demonstrated that glycogenes can function as important pleiotropic regulators of tumorigenesis. In this study, we investigated the function of endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase (MAN1B1) on the behavior of prostate cancer cells and found that overexpression of MAN1B1 in androgen-independent PC3 cells reduced cellular migration. We extended the analysis to an androgen dependent cell line, LNCaP, and another androgen independent cell line, LNCaP-AI, observing a similar migratory phenotype. By using quantitative proteomics, we found the downregulation of vimentin expression when PC3 or LNCaP-AI cells with overexpressed MAN1B1. The current study suggests that MAN1B1 may regulate cellular migration and promote epithelial-to-mesenchymal transition (EMT) phenotype in prostate cancer cells.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition
S.-H. Lin, Y.-C. Lee, … L.-y. Yu-Lee·bioRxiv·Nov 8, 2021
- TGF-β induces matrisome pathological alterations and EMT in patient-derived prostate cancer tumoroids
S. Fernandes, J. Oliver-De La Cruz, … G. Forte·bioRxiv·Apr 3, 2023
- RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.
B. Van Espen, H. Z. Oo, … Z. A. Ronai·bioRxiv·Jun 29, 2023
- TEAD1 regulates ITGA1 and ITGA2 to control prostate cancer progression
S. P. Cruz, Q. Zhang, … A. Manninen·bioRxiv·Apr 12, 2023
- Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development
Jinxia Zheng, Ling Li, … Sebastian Oltean·Frontiers in PharmacologyPeer-reviewed·Aug 18, 2026
- Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1
Alvaro Gonzalo-Paulano, Alice Macchia, … V Torrano·bioRxiv·May 8, 2026